The challenge of particles in sterile, injectable drug products has been a quandary that the pharmaceutical industry has been dealing with for more than a decade. Recalls due to particulate can not only cause shortages of much-needed drugs, but also seriously damage a company’s reputation and its bottom line.
Using a holistic approach to selecting and testing primary packaging and delivery systems can help pharmaceutical manufacturers mitigate particulate risk.
Join West’s Fran DeGrazio and John Rech as they discuss how to reduce particulate by focusing on:
- packaging materials
- particle testing methods for drugs and closures
- best practice analytics in evaluating particle methodologies
- original research on testing elastomeric components by subvisible particle methodologies
The webinar should be of interest to: drug product formulators, analytical testing personnel, QA&QC personnel, packaging engineers and manufacturing personnel along with others interested in the subject of particles in sterile drug products.